Business Description
![Cyclacel Pharmaceuticals Inc Cyclacel Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000JAM.png?14)
Cyclacel Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US23254L4059
Description
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 133.24 | |||||
Equity-to-Asset | -0.36 | |||||
Debt-to-Equity | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -110.53 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | 20 | |||||
3-Year FCF Growth Rate | 17 | |||||
3-Year Book Growth Rate | -80.7 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.12 | |||||
9-Day RSI | 41.15 | |||||
14-Day RSI | 42.2 | |||||
6-1 Month Momentum % | 11.43 | |||||
12-1 Month Momentum % | -70.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.58 | |||||
Quick Ratio | 0.58 | |||||
Cash Ratio | 0.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.5 | |||||
Shareholder Yield % | 2.41 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -5008.69 | |||||
Net Margin % | -4386.86 | |||||
FCF Margin % | -2177.78 | |||||
ROE % | -365.16 | |||||
ROA % | -149.29 | |||||
ROIC % | -974.64 | |||||
ROC (Joel Greenblatt) % | -17820.13 | |||||
ROCE % | -413.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.12 | |||||
EV-to-EBIT | 0.02 | |||||
EV-to-EBITDA | 0.02 | |||||
EV-to-Revenue | -0.87 | |||||
EV-to-Forward-Revenue | 0.03 | |||||
EV-to-FCF | 0.04 | |||||
Earnings Yield (Greenblatt) % | 5000 | |||||
FCF Yield % | -408.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyclacel Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.414 | ||
EPS (TTM) (€) | -20.639 | ||
Beta | -1.16 | ||
Volatility % | 98.35 | ||
14-Day RSI | 42.2 | ||
14-Day ATR (€) | 0.104417 | ||
20-Day SMA (€) | 1.5465 | ||
12-1 Month Momentum % | -70.73 | ||
52-Week Range (€) | 1.13 - 10.364999 | ||
Shares Outstanding (Mil) | 1.46 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cyclacel Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cyclacel Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cyclacel Pharmaceuticals Inc Frequently Asked Questions
What is Cyclacel Pharmaceuticals Inc(STU:UXI)'s stock price today?
The current price of STU:UXI is €1.45. The 52 week high of STU:UXI is €10.36 and 52 week low is €1.13.
When is next earnings date of Cyclacel Pharmaceuticals Inc(STU:UXI)?
The next earnings date of Cyclacel Pharmaceuticals Inc(STU:UXI) is 2024-08-09 Est..
Does Cyclacel Pharmaceuticals Inc(STU:UXI) pay dividends? If so, how much?
Cyclacel Pharmaceuticals Inc(STU:UXI) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |